Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cells ; 12(13)2023 06 28.
Article in English | MEDLINE | ID: mdl-37443769

ABSTRACT

The term 'perinatal environment' refers to the period surrounding birth, which plays a crucial role in brain development. It has been suggested that dynamic communication between the neuro-immune system and gut microbiota is essential in maintaining adequate brain function. This interaction depends on the mother's status during pregnancy and/or the newborn environment. Here, we show experimental and clinical evidence that indicates that the perinatal period is a critical window in which stress-induced immune activation and altered microbiota compositions produce lasting behavioral consequences, although a clear causative relationship has not yet been established. In addition, we discuss potential early treatments for preventing the deleterious effect of perinatal stress exposure. In this sense, early environmental enrichment exposure (including exercise) and melatonin use in the perinatal period could be valuable in improving the negative consequences of early adversities. The evidence presented in this review encourages the realization of studies investigating the beneficial role of melatonin administration and environmental enrichment exposure in mitigating cognitive alteration in offspring under perinatal stress exposure. On the other hand, direct evidence of microbiota restoration as the main mechanism behind the beneficial effects of this treatment has not been fully demonstrated and should be explored in future studies.


Subject(s)
Brain-Gut Axis , Brain , Cognitive Dysfunction , Maternal Exposure , Prenatal Exposure Delayed Effects , Stress, Psychological , Cognitive Dysfunction/immunology , Cognitive Dysfunction/microbiology , Cognitive Dysfunction/prevention & control , Humans , Female , Animals , Prenatal Exposure Delayed Effects/etiology , Melatonin/administration & dosage , Brain/growth & development , Neurogenesis , Antioxidants/administration & dosage , Probiotics/administration & dosage
2.
Pharmacol Res Perspect ; 9(5): e00795, 2021 10.
Article in English | MEDLINE | ID: mdl-34609083

ABSTRACT

Neurodegenerative diseases (NDD) are disorders characterized by the progressive loss of neurons affecting motor, sensory, and/or cognitive functions. The incidence of these diseases is increasing and has a great impact due to their high morbidity and mortality. Unfortunately, current therapeutic strategies only temporarily improve the patients' quality of life but are insufficient for completely alleviating the symptoms. An interaction between the immune system and the central nervous system (CNS) is widely associated with neuronal damage in NDD. Usually, immune cell infiltration has been identified with inflammation and is considered harmful to the injured CNS. However, the immune system has a crucial role in the protection and regeneration of the injured CNS. Nowadays, there is a consensus that deregulation of immune homeostasis may represent one of the key initial steps in NDD. Dr. Michal Schwartz originally conceived the concept of "protective autoimmunity" (PA) as a well-controlled peripheral inflammatory reaction after injury, essential for neuroprotection and regeneration. Several studies suggested that immunizing with a weaker version of the neural self-antigen would generate PA without degenerative autoimmunity. The development of CNS-related peptides with immunomodulatory neuroprotective effect led to important research to evaluate their use in chronic and acute NDD. In this review, we refer to the role of PA and the potential applications of active immunization as a therapeutic option for NDD treatment. In particular, we focus on the experimental and clinical promissory findings for CNS-related peptides with beneficial immunomodulatory effects.


Subject(s)
Autoantigens/therapeutic use , Autoimmunity/immunology , Immunologic Factors/therapeutic use , Nerve Regeneration/immunology , Neurodegenerative Diseases/therapy , Neuroprotection/immunology , Peptides/therapeutic use , Alzheimer Disease/immunology , Alzheimer Disease/therapy , Amyotrophic Lateral Sclerosis/immunology , Amyotrophic Lateral Sclerosis/therapy , Animals , Glatiramer Acetate/therapeutic use , Humans , Immunization, Passive , Immunomodulation , Myelin Basic Protein/therapeutic use , Neurodegenerative Diseases/immunology , Parkinson Disease/immunology , Parkinson Disease/therapy , Peptide Fragments/therapeutic use , Proteostasis Deficiencies , Spinal Cord Injuries/immunology , Spinal Cord Injuries/therapy , Stroke/immunology , Stroke/therapy
3.
Stress ; 24(6): 987-997, 2021 11.
Article in English | MEDLINE | ID: mdl-34581257

ABSTRACT

During gestation, stress exposure increases the risk of developing cognitive and physiological alterations in either the long or short term. Among them, metabolic alterations have been described. Adipose tissue is responsible for the secretion of several factors involved in controlling body weight and energy expenditure, the regulation of insulin sensitivity, and the development of inflammation, among others. Moreover, the liver regulates glucose homeostasis and lipid metabolism, playing an essential role in developing insulin resistance. In this work, we analyzed if prenatal stress leads to alterations in metabolism and the relationship between these alterations and gene expression in the adipose tissue and the liver. Prenatal stress-exposed animals developed disturbances in the glucose and insulin response curve, showing in both tests higher glycemia than the control group. However, they did not exhibit increased body weight. At the same time, in the adipose tissue, we observed an increase in mRNA expression of Leptin and Resistin and a decrease in Adiponectin. In the liver, we observed a lower mRNA expression of several genes involved in glucose metabolism and fatty acid oxidation, such as Sirt1, Pgc1α, Pparα, among others. In both tissues, we observed a lower expression of inflammatory genes. These results suggest that prenatal stress exposure produces insulin resistance at both physiological and molecular levels without pro-inflammatory signaling or obesity.


Subject(s)
Insulin Resistance , Adipose Tissue/metabolism , Animals , Female , Inflammation/metabolism , Insulin , Insulin Resistance/genetics , Male , Mice , Mice, Inbred C57BL , Obesity/metabolism , Pregnancy , Stress, Psychological
4.
J Dev Orig Health Dis ; 12(5): 721-730, 2021 10.
Article in English | MEDLINE | ID: mdl-33118903

ABSTRACT

Prenatal insults during fetal development result in increased likelihood of developing chronic disease. Obesity, the biggest risk factor for the development of metabolic disease, is affected by several genetic and environmental factors. High-fat diet (HFD) consumption is usually linked with the development of obesity. The main goal of this study was to analyze the impact of the exposure to a HFD in prenatally stressed animals. For this purpose, we subjected pregnant BALB/c mice to restraint stress for 2 h a day between gestational day (GD) 14 and GD 21. Prenatally stressed and control offspring of both sexes were postnatally exposed to a HFD for 24 weeks. We found that prenatal stress (PS) per se produced disturbances in males such as increased total blood cholesterol and triglycerides, with a decrease in mRNA expression of sirtuin-1. When these animals were fed a HFD, we observed a rise in glucose and insulin levels and an increase in visceral adipose tissue gene expression of leptin, resistin, and interleukin-1 beta. Although females proved to be more resilient to PS consequences, when they were fed a HFD, they showed significant metabolic impairment. In addition to the changes observed in males, females also presented an increase in body weight and adiposity and a rise in cholesterol levels.


Subject(s)
Diet, High-Fat/adverse effects , Metabolic Diseases/etiology , Mice, Inbred BALB C/metabolism , Animals , Diet, High-Fat/methods , Disease Models, Animal , Female , Metabolic Diseases/diet therapy , Mice , Mice, Inbred BALB C/abnormalities , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...